C39H45N9O5
Neat
719.85
Zelebrudomide; (R)-NX-2127; CHEMBL5435454; 3024312-52-2; Zelebrudomide (USAN); ZELEBRUDOMIDE [USAN]; Zelebrudomide, (S)-; 3-((4-(1-(((3R)-1-(2-(2, 6-Dioxopiperidin-3-yl)-1 and 3-dioxoisoindolin-5-yl)pyrrolidin-3-yl)methyl)piperidin-4-yl)phenyl)amino)-5-(piperidin-1-yl)pyrazine-2-carboxamide; Zelebrudomida; zelebrudomide [INN]; C9V5FHZ2L3; SCHEMBL24833161; GTPL12519; GLXC-27119; EX-A8876; BDBM50622926; HY-153220A; CS-0783592; D12858; H41286
3-[4-[1-[[(3R)-1-[2-(2, 6-dioxopiperidin-3-yl)-1 and 3-dioxoisoindol-5-yl]pyrrolidin-3-yl]methyl]piperidin-4-yl]anilino]-5-piperidin-1-ylpyrazine-2-carboxamide
InChI=1S/C39H45N9O5/c40-35(50)34-36(43-32(21-41-34)46-15-2-1-3-16-46)42-27-6-4-25(5-7-27)26-13-17-45(18-14-26)22-24-12-19-47(23-24)28-8-9-29-30(20-28)39(53)48(38(29)52)31-10-11-33(49)44-37(31)51/h4-9,20-21,24,26,31H,1-3,10-19,22-23H2,(H2,40,50)(H,42,43)(H,44,49,51)/t24-,31?/m1/s1